Ziprasidone Impurity 15 CAS CATO-C4X-124015
| CAS No. | CATO-C4X-124015 |
| Molecular Formula | C18H14Cl2N2O2 |
| Molecular Weight | 361.22 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.
As a process- or degradation-related impurity, Ziprasidone Impurity 15 (CAS CATO-C4X-124015, C18H14Cl2N2O2) is essential for impurity profiling, related-substances testing, and forced-degradation studies in pharmaceutical development.
The molecular framework of Ziprasidone Impurity 15 (C18H14Cl2N2O2) is characterized by a steroid core, an amide group, a hydroxyl group, an ether linkage, chlorine substitution. In reversed-phase chromatography, its retention is governed primarily by its high hydrophobicity (logP), which provides a practical basis for HPLC-UV/DAD or LC-MS method development. The aromatic system may exhibit native fluorescence, enabling detection with a fluorescence detector (FLD).
CATO manufactures Ziprasidone Impurity 15 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C18H14Cl2N2O2 |
| Molecular Weight | 361.22 g/mol |
| Appearance | Pale yellow to yellow crystalline powder. (slight halide-like odor, low volatility) |
| Purity | 97%+ |
| Storage | Store at 2-8°C, protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening; Contains ester bond; hydrolyzes under strong alkaline conditions |
| Degree of Unsaturation (DBE) | 12.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| Halogen Content | Cl-containing |
| Nitrogen Atoms | 2 |
Related Ziprasidone Standards
- Ziprasidone Impurity 41 (CAS CATO-C4X-124041)
- Ziprasidone Impurity 22 (CAS 223586-82-1)
- Ziprasidone Impurity 14 (CAS CATO-C4X-124014)
- Ziprasidone Impurity 73 (CAS CATO-C4X-124073)
- Ziprasidone Impurity 10 (CAS 118305-72-9)
- Ziprasidone Impurity 68 (CAS CATO-C4X-124068)
- Ziprasidone Impurity 37 (CAS CATO-C4X-124037)
- Ziprasidone Impurity 35 (CAS CATO-C4X-124035)
Recommended Standards
- (R)-N-Boc-|A-(iodomethyl)benzeneethanamine 293305-69-8 N-[(1R)-1-(Iodomethyl)-2-phenylethyl]carbamic Acid 1,1-Dimethylethyl Ester (CAS 293305-69-8)
- Ixazomib Impurity 81 (CAS CATO-C4X-126781)
- tert-Butyl 5-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate (CAS 2095464-28-9)
- 2-[(2-Bromoacetyl)amino]-N-ethyl-N-phenylbenzamide (CAS 1138442-64-4)
- Flumazenil (N-[11C]Methyl) EP Impurity A (CAS 79089-72-8)
- Tinidazole Impurity 5 (CAS CATO-C4X-19305)
- Deoxycholic acid Impurity 21 (CAS 73410-01-2)
- 4-((3-(2-Methoxyethoxy)phenyl)amino)-4-oxobutanoic acid (CAS 925038-25-1)
- (2R,3S,4S,5R)-2,3,4,5-tetrahydroxy-6-oxohexanoic acid (CAS 2073-35-0)
- 2,2,2-Trifluoro-N-{6-oxo-4h,5h,6h-cyclopenta[b]thiophen-4-yl}acetamide (CAS 108046-14-6)
- 3-(3-(Furan-2-yl)-1,2,4-oxadiazol-5-yl)-N-(thiophen-2-yl)azetidine-1-carboxamide (CAS 1448075-58-8)
- (Z)-2-(2-Oxoindolin-3-ylidene)acetic acid (CAS 61854-73-7)
- 1-Butyl-5-(5-fluoro-2-hydroxybenzoyl)-2-oxo-1,2-dihydropyridine-3-carbonitrile (CAS 1087634-93-2)
- Neuropeptide S (rat) (CAS 412938-75-1)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com